Interview Times The aggregate COVID-19 vaccine dosages administered within the nation outperformed the 100-crore breakthrough today. Concurring to the government’s CoWin site, over 70 crore people have been administered the first dose of the COVID-19 vaccine whereas 29 crores have received the full doses.
The top states which have administered the most elevated number of doses are:
Uttar Pradesh followed by Maharashtra, West Bengal, Gujarat, and Madhya Pradesh.
As the nation accomplished the milestone of administrating 100 crores COVID-19 vaccination mark, Prime Minister Narendra Modi on Thursday said “India scripted history” and expressed his gratitude to doctors, nurses, and all those who worked to achieve this feat.
“India scripts history. We are witnessing the triumph of Indian science, enterprise, and collective spirit of 130 crore Indians. Congrats India on crossing 100 crore vaccinations. Gratitude to our doctors, nurses, and all those who worked to achieve this feat. #VaccineCentury,” PM Modi tweeted.
https://twitter.com/narendramodi/status/1451051712387731458
The countrywide vaccination drive was rolled out on January 16 with health care workers (HCWs) getting inoculated in the first phase. The vaccination of frontline workers(FLWs) started on February 2.
The next phase of COVID-19 vaccination commenced from March 1 for people over 60 years of age and those aged 45 and above with specified co-morbid conditions. The country launched vaccination for all people aged over 45 years from April 1. The government then decided to expand its vaccination drive by allowing all above 18 to be vaccinated from May 1.
In India, three vaccines have been in emergency use namely, Covishield (Oxford AstraZeneca’s vaccine manufactured by Serum Institute of India), Covaxin (manufactured by Bharat Biotech Limited), and Sputnik V (developed by Gamaleya Research Institute, Russia).
Drugs Controller General of India (DCGI) has also granted Emergency Use Authorization (EUA) to three other vaccines by Moderna, Johnson and Johnson, and Zydus Cadila, two of which are expected to help ramp up the vaccination drive by October-November.
On January 3, India approved COVID-19 vaccines Covishield and Covaxin for emergency use.
(With the inputs of government sources and News Agencies).
